EQUILLIUM, INC. Increase (Decrease) in Accounts Payable
EQUILLIUM, INC. (EQ) reported Increase (Decrease) in Accounts Payable of $89.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-13
- EQUILLIUM, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$345.00K, a 119.77% decline year-over-year.
- EQUILLIUM, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $434.00K, a 13.91% increase year-over-year.
- EQUILLIUM, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$33.00K.
- EQUILLIUM, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$4.03M.
- EQUILLIUM, INC. increase (decrease) in accounts payable for fiscal 2025 was -$1.94M.
- EQUILLIUM, INC. increase (decrease) in accounts payable for fiscal 2024 was -$2.00M, a 375.93% decline from fiscal 2023.
- EQUILLIUM, INC. increase (decrease) in accounts payable for fiscal 2023 was $723.00K, a 71.17% decline from fiscal 2022.
- EQUILLIUM, INC. increase (decrease) in accounts payable for fiscal 2022 was $2.51M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 7 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 10 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$345.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $89.00K 10-Q · filed 2026-08-13 | $56.00K derived: sum of 3 quarters · filed 2026-08-13 | -$3.97M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $434.00K 10-Q · filed 2026-05-13 | $401.00K derived: sum of 2 quarters · filed 2026-05-13 | -$3.63M derived: sum of 3 quarters · filed 2026-05-13 | -$1.88M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$4.06M derived: sum of 2 quarters · filed 2026-03-25 | -$2.32M derived: sum of 3 quarters · filed 2026-08-13 | -$1.94M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$4.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.29M derived: sum of 2 quarters · filed 2026-08-13 | -$1.90M 10-Q · filed 2025-11-13 | -$2.85M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.13M 10-Q · filed 2026-08-13 | $1.18M derived: sum of 3 quarters · filed 2026-08-13 | $334.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $381.00K 10-Q · filed 2026-05-13 | -$568.00K derived: sum of 2 quarters · filed 2026-05-13 | -$1.41M derived: sum of 3 quarters · filed 2026-05-13 | $345.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$949.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$1.79M derived: sum of 2 quarters · filed 2026-03-25 | -$36.00K derived: sum of 3 quarters · filed 2026-03-25 | -$2.00M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | -$843.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $913.00K derived: sum of 2 quarters · filed 2025-11-13 | -$1.05M 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$203.00K 10-Q · filed 2025-08-14 | $843.00K derived: sum of 3 quarters · filed 2025-08-14 | $1.45M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$1.96M 10-Q · filed 2025-05-14 | -$913.00K derived: sum of 2 quarters · filed 2025-05-14 | -$306.00K derived: sum of 3 quarters · filed 2025-05-14 | -$2.96M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $1.65M derived: sum of 2 quarters · filed 2025-03-27 | -$1.00M derived: sum of 3 quarters · filed 2025-03-27 | $723.00K 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $607.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$2.05M derived: sum of 2 quarters · filed 2024-11-13 | -$323.00K 10-Q · filed 2024-11-13 | $1.18M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$2.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$930.00K 10-Q · filed 2024-08-08 | $568.00K derived: sum of 3 quarters · filed 2024-08-08 | -$2.04M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $1.73M 10-Q · filed 2024-05-09 | $3.22M derived: sum of 2 quarters · filed 2024-05-09 | $611.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.54M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$1.11M derived: sum of 2 quarters · filed 2024-03-25 | -$184.00K derived: sum of 3 quarters · filed 2024-03-25 | $2.51M 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | -$2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.68M derived: sum of 2 quarters · filed 2023-11-08 | $1.01M 10-Q · filed 2023-11-08 | -$464.00K derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $931.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.62M 10-Q · filed 2023-08-09 | $2.15M derived: sum of 3 quarters · filed 2023-08-09 | $3.02M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $2.69M 10-Q · filed 2023-05-11 | $1.22M derived: sum of 2 quarters · filed 2023-05-11 | $2.08M derived: sum of 3 quarters · filed 2023-05-11 | $1.60M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$607.00K derived: sum of 2 quarters · filed 2023-03-23 | -$1.09M derived: sum of 3 quarters · filed 2023-03-23 | -$1.58M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $867.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $385.00K derived: sum of 2 quarters · filed 2022-11-14 | -$104.00K 10-Q · filed 2022-11-14 | $1.02M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$482.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$971.00K 10-Q · filed 2022-08-15 | $152.00K derived: sum of 3 quarters · filed 2022-08-15 | $23.00K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$489.00K 10-Q · filed 2022-05-12 | $634.00K derived: sum of 2 quarters · filed 2022-05-12 | $505.00K derived: sum of 3 quarters · filed 2022-05-12 | $444.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $994.00K derived: sum of 2 quarters · filed 2022-03-23 | $933.00K derived: sum of 3 quarters · filed 2022-03-23 | $894.00K 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | -$129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$190.00K derived: sum of 2 quarters · filed 2021-11-10 | -$229.00K 10-Q · filed 2021-11-10 | -$1.01M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$100.00K 10-Q · filed 2021-08-10 | -$884.00K derived: sum of 3 quarters · filed 2021-08-10 | -$215.00K derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | -$39.00K 10-Q · filed 2021-05-13 | -$823.00K derived: sum of 2 quarters · filed 2021-05-13 | -$154.00K derived: sum of 3 quarters · filed 2021-05-13 | $281.00K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$784.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -$115.00K derived: sum of 2 quarters · filed 2021-03-24 | $320.00K derived: sum of 3 quarters · filed 2021-03-24 | $775.00K 10-K · filed 2021-03-24 | ||||
| 2019-09-30 | $669.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $1.10M derived: sum of 2 quarters · filed 2020-11-10 | $1.56M 10-Q · filed 2020-11-10 | $2.05M derived: sum of 4 quarters · filed 2020-11-10 | ||||
| 2019-06-30 | $435.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $890.00K 10-Q · filed 2020-08-12 | $1.38M derived: sum of 3 quarters · filed 2020-08-12 | $1.63M derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | $455.00K 10-Q · filed 2020-05-13 | $945.00K derived: sum of 2 quarters · filed 2020-05-13 | $1.20M derived: sum of 3 quarters · filed 2020-05-13 | $1.30M derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $490.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $740.00K derived: sum of 2 quarters · filed 2020-03-26 | $847.00K derived: sum of 3 quarters · filed 2020-03-26 | $843.00K 10-K · filed 2020-03-26 | $842.72K 10-K · filed 2019-03-27 | |||
| 2018-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $357.00K derived: sum of 2 quarters · filed 2019-11-12 | $353.00K 10-Q · filed 2019-11-12 | $352.00K 10-Q · filed 2018-11-15 | ||||
| 2018-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $103.00K 10-Q · filed 2019-08-12 | ||||||
| 2018-03-31 | -$4.00K 10-Q · filed 2019-05-13 | |||||||
| 2017-12-31 | $243.74K 10-K · filed 2019-03-27 | |||||||
| 2017-09-30 | $33.27K 10-Q · filed 2018-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |